✦ LIBER ✦

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock

✍ Scribed by Edward Abraham; Antonio Anzueto; Guillermo Gutierrez; Sidney Tessler; Gerry San Pedro; Richard Wunderink; Anthony Dal Nogare; Stanley Nasraway; Steve Berman; Robert Cooney; Howard Levy; Robert Baughman; Mark Rumbak; R Bruce Light; Lona Poole; Randy Allred; John Constant; James Pennington; Steven Porter

Book ID: 117288383
Publisher: The Lancet
Year: 1998
Tongue: English
Weight: 672 KB
Volume: 351
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)60602-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind randomised controlled trial

Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock: Abraham E, Anzueto A, Gutierrez G, et al: Lancet 351: 929–933, 1998

📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Randomised controlled trial of CDP571 an

Randomised controlled trial of CDP571 antibody to tumour necrosis factor-α in Crohn's disease

✍ WA Stack; SD Mann; AJ Roy; P Heath; M Sopwith; J Freeman; G Holmes; R Long; A Fo 📂 Article 📅 1997 🏛 The Lancet 🌐 English ⚖ 400 KB

Randomised double-blind comparison of ch

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor α (cA2) versus placebo in rheumatoid arthritis

✍ M.J Elliott; R.N Maini; M Feldmann; J.R Kalden; C Antoni; J.S Smolen; B Leeb; F. 📂 Article 📅 1994 🏛 The Lancet 🌐 English ⚖ 797 KB

Treatment of septic shock with human mon

Treatment of septic shock with human monoclonal antibody HA-1A: A randomized, double-blind, placebo-controlled trial: Ann Intern Med 1994; 121/1; 1–5

✍ RV McCloskey; RC Straube; C Sanders; SM Smith; CR Smith 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 249 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled trial of CDP571, a humanized monoclonal antibody to tumour necrosis factor-α, in patients with corticosteroid-dependent Crohn's disease

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Secukinumab, a human anti-IL-17A monoclo

Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

✍ Hueber, W.; Sands, B. E.; Lewitzky, S.; Vandemeulebroecke, M.; Reinisch, W.; Hig 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 304 KB